Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Advanced Medicine

Hands Off the Goods

| Chris Procyshyn

Aseptic filling is the final manufacturing step but it shouldn’t be an afterthought. It’s time to adopt closed, automated processes for the drugs of today and tomorrow.

Manufacture Advanced Medicine

Point of Care, Point of Commercialization

| James Strachan

What if research hospitals could fully develop and process cell and gene therapies themselves? UC Davis joins Orgenesis’ point-of-care network to develop and commercialize cell and gene therapies in house.

Discovery & Development Drug Discovery

Sharing is Caring

Sitting down with… Matthew Todd, Chair of Drug Discovery at UCL and founder of the Open Source Pharma movement to discuss why open source pharma is so compelling.

Register to personalize your newsfeed

Create Account

Latest Articles

Manufacture Bioprocessing - Upstream & Downstream

Biopharma's Big Transformation

| Sponsored by GE Healthcare

Digital technology, data analytics and continuous processing. The world of biopharma is changing rapidly.

Discovery & Development Clinical Trials

Failing Safely: Why Ending Some Programmes Early May Be a Recipe for Successes Later.

| Adrian Wildfire

Why are compounds still failing at the final hurdle?

Business & Regulation Business Practice

Image of the Month: Tracked and Traced

A collaboration for improved supply chain visibility.

Manufacture Clinical Trials

Rising to the ADC Challenge

| Maryam Mahdi

What challenges do manufacturers face in developing ADCs?

Business & Regulation Business Practice

Business-in-Brief

| Maryam Mahdi

Fines, approvals and anniversaries...What’s new in business?

Discovery & Development Analytical Science

A New Dawn in Biological Therapies?

| Sponsored by Tosoh

Explore TOSOH’s expertise across all stages of therapeutic antibody development.

Manufacture Advanced Medicine

Driving CAR T Cell Therapy

| James Strachan

John Rossi, Director of Translational Sciences at Kite Pharma, talks about bright future of CAR T cell therapy.

Manufacture Advanced Medicine

How to Commercialize a CAR T Cell Therapy

| James Strachan

Dick Sundh, Head of Europe at Kite, explains what it takes to commercialize CAR T cell therapy.

Manufacture Advanced Medicine

Ahead of the Curve

| James Strachan

Ravi Nalliah explains his journey from biochemistry and molecular biology student, to chartered accountant, to supply chain CDMO founder.

Manufacture Advanced Medicine

CAR T Cell Therapy: Redefining Quality

| Bethany Dudek

Here we explore the challenges involved in ensuring CAR T cell therapies are delivered to patients safely and as quickly as possible.

All Articles

Upcoming Events

-

CAR-TCR Europe Summit

London, UK

With CAR-T therapies on the cusp of achieving global approval, there are still many bottlenecks that are preventing this...

-

Pittcon 2020: The Clear Advantage in Laboratory Science Conferences and Expositions

Chicago, USA

Join your peers at Pittcon 2020, the world’s annual leading science conference and exposition for Laboratory Science,...

-

2020 ISPE Aseptic Conference

North Bethesda, MD, USA

Now in its 29th year, 2020 SPE Aseptic Conference has established itself as the pharmaceutical industry's leading source...

All Events


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register